alexa In Vivo Diagnosis: A Future Direction for Biochip Technology | OMICS International | Abstract
ISSN: 2153-0777

Journal of Bioengineering and Bioelectronics
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

In Vivo Diagnosis: A Future Direction for Biochip Technology

Liping Tang*
Department of Bioengineering, University of Texas at Arlington, Arlington, Texas-76001, USA
Corresponding Author : Dr. Liping Tang
Department of Bioengineering
University of Texas at Arlington
Arlington, Texas-76001, USA
E-mail: [email protected]
Received August 31, 2010; Accepted September 05, 2011; Published October 29, 2011
Citation: Tang L (2011) In Vivo Diagnosis: A Future Direction for Biochip Technology. J Biochip Tissue chip S1:002. doi:10.4172/2153-0777.S1-e002
Copyright: © 2011 Tang L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Biochip technology has enjoyed rapid growth in a wide variety of research fields including genome, proteome and pharmaceutical in recent years. This rapid progress may be partially attributed to substantial research efforts on the improvement of biochip fabrication technology, which has greatly enhanced the sensitivity and reproducibility of biochips. On the other hand, rigorous research efforts have been made toward the development of a broad spectrum of microprobes, including DNA microarrays, protein microarrays, antibody microarrays and chemical microarrays, for both basic research and clinical diagnosis. It should be noted however that almost all of these biochips are designed for in vitro testing, screening or diagnosis. Despite their prospective use as powerful tools for basic medical research and medical diagnosis, the potential use of biochip technology for in vivo diagnosis has yet to be studied in depth.

Top